Sweet violet (Viola odorata)
Also called Viola odorata, violet flower, violet syrup, violet oil, banafsheh, English violet.
Best grade C across 9 graded outcomes Botanical Last checked
The short answer
From 11 sourcesSweet violet is a flowering herb from Persian medicine, tested as an oral syrup and as nasal or skin oil. Small Iranian trials report better sleep scores in insomnia and menopause, faster cough relief added to usual care, and single trials of the oil for dry eye and dialysis itch. Trials are short and doses vary.
Every graded outcome on this page
9 rows · line = participants- CGrade CInsomnia scores across trialsSleepn 224
- CGrade CCough in children with intermittent asthma (add-on)Coughn 182
- CGrade CCOVID-19 symptoms in outpatients (add-on)Coughn 108
- CGrade CSleep quality in menopausal womenSleepn 84
- CGrade CInsomnia in people with depression or OCD (add-on)Sleepn 83
- DGrade DDry eye: tear production and symptoms (nasal violet oil)Violet extract in almond oil, nasal dropsn 91
- DGrade DChronic insomnia (nasal violet oil)Sleepn 75
- DGrade DItch and dry skin in hemodialysis (topical oil with massage)Violet oil applied with massagen 57
- DGrade DFever in children with neutropenia (topical oil)Fevern 41
- 6 more graded outcomes, in the evidence chapter
Key facts
- Sleep, menopause
- Violet syrup 5 mL twice daily for a month cut PSQI scores from 9.2 to 4.9 vs 8.4 to 8.1 with placebo in 84 women1
- Insomnia overall
- A meta-analysis of 5 trials (224 people) found PSQI 4.67 points better than placebo7
- Cough in children
- Added to standard asthma care, violet syrup shortened time to cough relief in 182 children4
What it is
Sweet violet (Viola odorata) is a flowering plant used in Persian medicine as a syrup for sleep and cough and as an oil for nasal drops.
How it works
ProposedHow sweet violet affects sleep or cough is not established in humans. Trial authors cite traditional Persian use and laboratory anti-inflammatory and antitussive activity; no human mechanism studies were found.6
Forms, side by side
3 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Sweet violet (Viola odorata) forms compared
3 forms| 3 forms | Violet flower syrup (oral) | Violet oil nasal drops (extract in almond or sesame oil) | Violet oil applied to the skin |
|---|---|---|---|
| Absorption in people | Not reported.1246 | Not reported.38 | Not reported.511 |
| GI tolerance | No serious problems described in 1-month trials.1246 | Some mild complaints and no serious adverse events in a 50-person study.38 | Not reported in the trial abstracts.511 |
| Studied for | Sleep, cough | Insomnia; dry eye (one trial) | Fever in children (single application, in hospital); itch in hemodialysis (with massage) |
- Violet flower syrup (oral)
- Studied for
- Sleep, cough
- Violet oil nasal drops (extract in almond or sesame oil)
- Studied for
- Insomnia; dry eye (one trial)
- Violet oil applied to the skin
- Studied for
- Fever in children (single application, in hospital); itch in hemodialysis (with massage)
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
9 graded outcomes, largest study firstAll 9 graded outcomes found an improvement. The largest, a 2022 meta-analysis of 224 people on insomnia scores across trials, found an improvement.
1Insomnia scores across trials
Improved · Grade C · Meta-analysis, 224 people, 2022
Adults with chronic insomnia (5 trials)
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Insomnia scores across trials | Improved | 224 | Grade C · Meta-analysis, 2022 | Adults with chronic insomnia (5 trials) |
| Cough in children with intermittent asthma (add-on) | Improved | 182 | Grade C · RCT, 2015 | Children aged 2-12 with intermittent asthma (Iran) |
| COVID-19 symptoms in outpatients (add-on) | Improved | 108 | Grade C · RCT, 2023 | Adult COVID-19 outpatients (Isfahan, Iran) |
| Dry eye: tear production and symptoms (nasal violet oil) | Improved | 91 | Grade D · RCT, 2019 | Adults aged 18–60 with dry eye symptoms |
| Sleep quality in menopausal women | Improved | 84 | Grade C · RCT, 2024 | Menopausal women (Mashhad, Iran) |
| Insomnia in people with depression or OCD (add-on) | Improved | 83 | Grade C · Pilot RCT, 2020 | Adults with mild-moderate depression (40) or OCD (43) and insomnia (Tehran, Iran) |
| Chronic insomnia (nasal violet oil) | Improved | 75 | Grade D · RCT, 2018 | Adults with chronic insomnia (Mashhad, Iran) |
| Itch and dry skin in hemodialysis (topical oil with massage) | Improved | 57 | Grade D · RCT, 2019 | Hemodialysis patients with uremic pruritus |
| Fever in children with neutropenia (topical oil) | Improved | 41 | Grade D · RCT, 2020 | Febrile neutropenic children in hospital (Shiraz, Iran) |
Every graded row
9 rowsShowing 9 of 9 outcomes. Human trials only.
CGrade CInsomnia scores across trialsSleepPSQI -4.67 vs placeboMeta-analysis · 5 studies
n 224 · 2022
Improved Total PSQI improved by 4.67 points and ISI by 6.30 points vs placebo; sleep latency, efficiency and daytime dysfunction did not differ significantly.
- Design
- Meta-analysis, 5 studies, n = 224, 2022
- Population
- Adults with chronic insomnia (5 trials)
- Form
- Viola odorata preparations (syrup or nasal oil)
- Dose
- Varied by trial
- Duration
- About 1 month
- Source
- Reference 7 · PubMed 35734476 (opens PubMed)
CGrade CCough in children with intermittent asthma (add-on)CoughFaster cough reliefRCT
n 182 · 2015
Improved Time to a 50% cough reduction and to full cough suppression was shorter with violet syrup (P = .001 and < .001).
- Design
- RCT, n = 182, 2015
- Population
- Children aged 2-12 with intermittent asthma (Iran)
- Form
- Violet flower syrup vs placebo, with a short-acting beta-agonist
- Dose
- Dose not stated in the abstract
- Duration
- Until cough resolved
- Source
- Reference 4 · PubMed 25954025 (opens PubMed)
CGrade CCOVID-19 symptoms in outpatients (add-on)CoughFaster symptom reliefRCT
n 108 · 2023
Improved All symptoms improved in both groups; cough (P = 0.025), muscle pain, headache and diarrhoea fell more with violet syrup.
- Design
- RCT, n = 108, 2023
- Population
- Adult COVID-19 outpatients (Isfahan, Iran)
- Form
- Violet syrup vs placebo syrup, added to usual care
- Dose
- Dose not stated in the abstract
- Duration
- 7 days
- Source
- Reference 6 · PubMed 36535329 (opens PubMed)
CGrade CSleep quality in menopausal womenSleepPSQI about 3 points betterRCT
n 84 · 2024
Improved PSQI sleep score fell from 9.2 to 4.9 with violet syrup vs 8.4 to 8.1 with placebo (P < 0.001).
- Design
- RCT, n = 84, 2024
- Population
- Menopausal women (Mashhad, Iran)
- Form
- Viola odorata syrup vs placebo syrup
- Dose
- 5 mL twice daily
- Duration
- 1 month
- Source
- Reference 1 · PubMed 38177831 (opens PubMed)
CGrade CInsomnia in people with depression or OCD (add-on)SleepBetter sleep scoresPilot RCT
n 83 · 2020
Improved Total PSQI improved vs placebo in both the depression and OCD arms (p < 0.001); depression (BDI-II) and OCD (Y-BOCS) scores also improved.
- Design
- Pilot RCT, n = 83, 2020
- Population
- Adults with mild-moderate depression (40) or OCD (43) and insomnia (Tehran, Iran)
- Form
- Viola odorata syrup vs placebo syrup, added to usual treatment
- Dose
- 5 mL every 12 hours
- Duration
- 4 weeks
- Source
- Reference 2 · PubMed 32073874 (opens PubMed)
DGrade DDry eye: tear production and symptoms (nasal violet oil)Healthy agingImprovedRCT
n 91 · 2019
Improved Schirmer tear test, tear breakup time and the Ocular Surface Disease Index improved more with violet-almond oil than with almond oil alone or placebo (p < 0.05); Oxford staining grade did not differ.
- Design
- RCT, n = 91, 2019
- Population
- Adults aged 18–60 with dry eye symptoms
- Form
- Violet extract in almond oil, nasal drops
- Dose
- 2 drops three times daily
- Duration
- 1 month
- Source
- Reference 10 · PubMed 31060104 (opens PubMed)
DGrade DChronic insomnia (nasal violet oil)SleepLargest sleep-score gain of three armsRCT
n 75 · 2018
Improved Insomnia Severity Index and PSQI improved in all three groups; the violet oil group improved most (between-group P < 0.002 and < 0.001).
- Design
- RCT, n = 75, 2018
- Population
- Adults with chronic insomnia (Mashhad, Iran)
- Form
- Violet oil nasal drops vs almond oil vs placebo drops
- Dose
- 3 drops per nostril nightly
- Duration
- 30 days
- Source
- Reference 3 · PubMed 29217495 (opens PubMed)
DGrade DItch and dry skin in hemodialysis (topical oil with massage)Hair & skinImprovedRCT
n 57 · 2019
Improved Both groups improved; massage with violet oil reduced skin dryness and itch severity, location and frequency more than massage alone.
- Design
- RCT, n = 57, 2019
- Population
- Hemodialysis patients with uremic pruritus
- Form
- Violet oil applied with massage
- Dose
- 5 mL per 7-minute massage session
- Duration
- 6 sessions over 2 weeks
- Source
- Reference 11 · PubMed 31331569 (opens PubMed)
DGrade DFever in children with neutropenia (topical oil)FeverFewer rescue paracetamol dosesRCT
n 41 · 2020
Improved Temperature fell at 30 minutes with violet oil but not placebo; fewer children needed rescue paracetamol (5 vs 17).
- Design
- RCT, n = 41, 2020
- Population
- Febrile neutropenic children in hospital (Shiraz, Iran)
- Form
- Viola odorata oil rubbed around the navel vs placebo
- Dose
- 20 drops topically
- Duration
- Single application, followed 4 hours
- Source
- Reference 5 · PubMed 31250761 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Menopause trial: about a 4-point gap
PSQI fell 4.3 points with violet syrup and 0.3 points with placebo, a difference of about 4 points over one month.1
Better scores, not faster sleep
Pooled across 224 people, overall sleep-quality and insomnia scores improved, but sleep latency, sleep efficiency and daytime function did not differ from placebo.7
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Doses studied in human trials ranged from 5 mL of violet syrup twice daily for 1-4 weeks to 2-3 nasal drops of violet oil per nostril nightly, or 2 drops three times daily, for a month; skin oil was used as 20 drops once or 5 mL per massage session. These are research doses, not recommendations.123581011
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Sweet violet and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Sweet violet.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
5 groups- People on sleep medicines or sedatives
- Violet is studied for sleep, but no trial has tested it with sleeping pills, benzodiazepines or other sedatives, so any added effect is unknown.17
- People on other medicines
- No published drug-interaction study or case report was found for sweet violet, and the cited trials describe none, so effects with blood thinners, diabetes drugs or other medicines are unknown. NCCIH notes that supplements can interact with medicines.1269
- People with asthma
- The asthma trial used violet syrup only alongside a short-acting beta-agonist; it was not tested as a replacement for asthma medicine.4
- Children
- Children were studied only in an add-on cough trial and a topical fever trial in hospital.45
- Pregnancy and breastfeeding
- NCCIH notes that many dietary supplements have not been tested in pregnant women or nursing mothers, and no sweet violet trial enrolled them.9
How to read the label
What to check on the Supplement Facts panel.
How to read the label
3 checksSyrup, nasal oil or skin oil
Volume, not milligrams
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes sweet violet help sleep?
Does violet syrup help a cough?
Does sweet violet interact with medicines?
Is sweet violet the same as African violet?
No. Sweet violet is Viola odorata; African violets are unrelated houseplants (Saintpaulia).
How is violet oil used for sleep?
How strong is the evidence?
Low to moderate: trials are small, short, mostly from Iran, and mix different forms and doses.7
Sources
11 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
11 sources- 1Effects of Viola odorata syrup on sleep quality in menopausal women: a randomized, triple-blind, controlled trial.RCT Sleep Breath, 2024 · PMID 38177831
- 2Effects of Viola odorata as an Add-On Therapy on Insomnia in Patients with Obsession or Depression: A Pilot Randomized Double-Blind Placebo-Controlled Trial.Pilot RCT J Altern Complement Med, 2020 · PMID 32073874
- 3Efficacy of Violet oil, a traditional Iranian formula, in patients with chronic insomnia: A randomized, double-blind, placebo-controlled study.RCT J Ethnopharmacol, 2018 · PMID 29217495
- 4The Effect of Viola odorata Flower Syrup on the Cough of Children With Asthma: A Double-Blind, Randomized Controlled Trial.RCT J Evid Based Complementary Altern Med, 2015 · PMID 25954025
- 5The Effect of Viola Odorata L. Oil for Fever in Children: A Randomized Triple-blinded Placebo-controlled Clinical Trial.RCT Curr Drug Discov Technol, 2020 · PMID 31250761
- 6Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial.RCT J Ethnopharmacol, 2023 · PMID 36535329
- 7The Efficacy of V. odorata Extract in the Treatment of Insomnia: A Systematic Review and Meta-Analysis.Meta-analysis Front Neurol, 2022 · PMID 35734476
- 8Efficacy of Viola odorata in Treatment of Chronic Insomnia.Open-label trial Iran Red Crescent Med J, 2014 · PMID 25763239
- 9Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
- 10Effects of intranasal administration of violet oil in dry eye disease.RCT Clin Exp Optom, 2019 · PMID 31060104
- 11The effect of massage and topical violet oil on the severity of pruritus and dry skin in hemodialysis patients: A randomized controlled trial.RCT Complement Ther Med, 2019 · PMID 31331569
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| evidence, summary, forms, studied doses, who should be careful, label guide, insights, FAQ, related links, sources | Added two graded rows: a 2019 dry eye trial of nasal violet oil (PMID 31060104) and a 2019 trial of violet oil massage for itch in hemodialysis (PMID 31331569). New skin-oil form, two label-guide steps, two insights, an interactions FAQ and a sleep hub link. PubMed searched for Viola odorata trials and meta-analyses through 2026: the 2024 menopause trial remains the newest; a 2020 allergic rhinitis trial (PMID 32507426) has no abstract and was not added. Interactions: no study or case report found; the table stays empty and the medicines note says so. Fact-checked against the sources; corrected: the itch trial note no longer calls it unblinded, since the abstract does not report blinding. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| who should avoid | Pregnancy and breastfeeding caution re-sourced to NCCIH (agency source) instead of trial reports | Writer: Kymata Health EditorialTrigger: adversarial review |
| all | Initial editorial evidence review | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.